Does recurrent tonsillitis cause primary sclerosing cholangitis (PSC)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Recurrent tonsillitis is not known to cause Primary Sclerosing Cholangitis (PSC). PSC is a chronic liver disease characterized by inflammation and scarring of the bile ducts, both inside and outside the liver. The exact cause of PSC remains unclear, but it is believed to have an autoimmune component and is strongly associated with inflammatory bowel disease (particularly ulcerative colitis), not with recurrent tonsillitis 1. While some infections can trigger autoimmune responses in susceptible individuals, there is no established causal relationship between throat infections like tonsillitis and the development of PSC.

Some key points to consider:

  • The British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis do not mention recurrent tonsillitis as a risk factor for PSC 1.
  • The EASL clinical practice guidelines on sclerosing cholangitis discuss the potential role of antibiotics in the treatment of PSC, but do not suggest a link between recurrent tonsillitis and PSC 1.
  • The guidelines do recommend that long-term use of antibiotics is not recommended for treatment of PSC in the absence of recurrent bacterial cholangitis, with a strong recommendation and 100% consensus 1.

If you're experiencing symptoms of liver disease along with recurrent tonsillitis, these are likely separate conditions requiring different treatment approaches. For recurrent tonsillitis, treatment typically involves antibiotics for bacterial infections, such as penicillin or amoxicillin (500mg three times daily for 10 days), and in severe cases with frequent recurrences, tonsillectomy might be recommended. For PSC, management focuses on treating symptoms, monitoring for complications, and potentially using medications like ursodeoxycholic acid to improve bile flow. If you suspect you have PSC, it's essential to consult with a gastroenterologist or hepatologist for proper diagnosis through blood tests, imaging studies, and possibly liver biopsy.

From the Research

Relationship Between Recurrent Tonsillitis and Primary Sclerosing Cholangitis (PSC)

  • There is no direct evidence in the provided studies to suggest a link between recurrent tonsillitis and primary sclerosing cholangitis (PSC) 2, 3, 4, 5, 6.
  • The studies focus on the association of PSC with inflammatory bowel disease (IBD), autoimmune hepatitis, and other conditions, but do not mention recurrent tonsillitis as a potential cause or contributor to PSC.
  • The etiology of PSC is described as unknown, but it is believed to involve genetic susceptibility, immune dysregulation, and possibly abnormal innate immune responses and lymphocyte trafficking 5, 6.
  • The management and treatment of PSC are discussed in the studies, including the use of ursodeoxycholic acid, liver transplantation, and endoscopic treatment of dominant biliary strictures, but recurrent tonsillitis is not mentioned as a factor in the development or treatment of PSC 2, 3, 4, 5, 6.

Summary of PSC Causes and Associations

  • PSC is strongly associated with inflammatory bowel disease (IBD), particularly ulcerative colitis 2, 3, 4, 5, 6.
  • The disease is characterized by chronic inflammation and stricture formation of the biliary tree, leading to symptoms such as itch, lethargy, and cholangitis 2, 3, 4, 5, 6.
  • PSC is a rare disorder with a high risk of cholangiocarcinoma and colorectal cancer, and most patients ultimately require liver transplantation 3, 4, 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

ACG Clinical Guideline: Primary Sclerosing Cholangitis.

The American journal of gastroenterology, 2015

Research

Primary sclerosing cholangitis: diagnosis and management.

Current gastroenterology reports, 2006

Research

Primary sclerosing cholangitis: etiopathogenesis and clinical management.

Frontiers in bioscience (Elite edition), 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.